| INTRODUCTION
Hemoglobinopathies encompass all genetic diseases of hemoglobin (Hb). These genetic disturbances either affect the structure (hemoglobin variants) or the expression (thalassemias) of the different hemoglobin fractions. Almost 7% of the world population carries a mutation in globulin genes, of which most remain asymptomatic.
1 However, some of these mutations can cause clinically relevant anemia.
In the blood, hemoglobin circulates in the form of three physiological fractions that differ in their globin chain composition: the major fraction HbA0 (α2β2), the minor fraction HbA2 (α2δ2) and a small fraction HbF (α2γ2). Thalassemia syndromes are characterized by an altered synthesis ratio between the different globin chains that constitute these physiological hemoglobin fractions. α-and β-thalassemias have clinical significance as the affected α-and β-globin chains are the components of the main hemoglobin fraction HbA0. Modern automated devices used to quantify the glycated form of Hb (HbA1c) in diabetes diagnosis and follow-up are able to separate and quantitate the different hemoglobin fractions. This separation is achieved by electrophoresis or by high performance liquid chromatography (HPLC). Automated analyzers either measure HbA1c and screen for hemoglobinopathies in a single mode, or in two different dedicated modes on the same analyzer.
In the past decade, several studies evaluated and compared the performance of hemoglobin separation devices for hemoglobinopathy diagnosis. [2] [3] [4] [5] [6] In these studies, hemoglobinopathy analysis was executed in the dedicated Hb-pathy mode of the analyzers. However, the presence of a previously unknown hemoglobinopathy can be a coincidental finding in patients suspected of having diabetes during routine analysis in the HbA1c mode of the analyzer. Moreover, hemoglobin variants can interfere with HbA1c measurements, stressing the importance of their proper detection. Therefore, the evaluation of both Hb-pathy mode and HbA1c mode of the analyzers is of clinical relevance.
As newer versions of some hemoglobin separation devices were recently introduced, it was the aim of the present study to compare four commercially available analyzers in their ability to detect hemoglobinopathies, both in the hemoglobinopathy and in the HbA1c mode, if applicable.
| MATERIALS AND METHODS

| Samples
58 patient samples were tested: 32 samples containing a hemoglobin variant (9 HbA/S, 4 HbS/S, 9 HbA/E, 5 HbA/C, 2 HbA/D-Punjab, 1 HbA/Lepore, 1 HbA/J-Baltimore, 1 HbA/Muravera), 16 samples containing an aberrant value of HbA2 or HbF (of which 1 α-thalassemia and 6 β-thalassemia samples, all confirmed by molecular analysis) and 10 normal samples. Blood was collected in EDTA tubes. Normal samples were analyzed on fresh whole blood. All other samples were centrifuged (6 minutes at 1590 g) and red blood cell fractions were washed three times with NaCl 0.9% and stored at −80°C prior to analysis. All samples underwent only one thaw cycle before measurement. Furthermore, dedicated normal and abnormal quality controls for the specific mode of the specific analyzers were used for imprecision testing. 
| Analyzers
| D-100
The (see Table 1 ).
| HA 8180T
The HA 8180T was released in Europe in 2015 as the successor of the HA 8160. This HPLC analyzer is able to detect, identify and quantify hemoglobin variants and measure HbA1c, HbA0, HbF and HbA2 in a single mode. In addition to the HA 8180T, Menarini also distributes the HA 8180V which operates in either a fast mode for HbA1c quantification or a variant mode for HbA1c, HbF and variant quantification. The HA 8180V, however, was not tested in the current study.
One notable improvement of the HA 8180T compared to the former HA 8160 is the ability to identify HbS and HbC fraction in a separate window.
| HLC-723G8
HLC-723G8 is a HPLC analyzer that operates in two modes and is called "beta thalassemia mode". In order to avoid confusion, the "variant mode" on HLC-723G8 was named "HbA1c mode" and the "beta thalassemia mode" was named "Hb-pathy mode" throughout the manuscript.
| Capillarys 2 Flex Piercing
The Capillarys 2 Flex Piercing was released in Europe in 2011 as the successor of the Capillarys 2. This CE analyzer is equipped with eight parallel capillaries enabling multiple simultaneous analyses. One no- Piercing has a mixing system consisting of seven sample inversions, avoiding manual mixing.
For Hb separation, Capillarys operates in two modes. One mode is dedicated to HbA1c measurement, but HbF and HbA2 are also measured. Variants can be detected and quantified, but are not identified. The other mode is specially developed to separate different Hb variants, in order to correctly identify and quantify them. As with HLC-723G8, these modes were named "HbA1c mode" and "Hb-pathy mode" respectively throughout the manuscript. Variability between the eight capillaries was assessed prior to this study and proved to be lower than 3% for both the HbA1c and the Hb-pathy mode (data not shown).
Separation plots of the different analyzers are exemplified in Figure 1 , demonstrating the results for a heterozygous HbS sample.
| Analytical performances
| Imprecision
Imprecision was measured by analyzing the dedicated normal and abnormal quality controls for the specific mode of the specific analyzer on 10 different days. As the Capillarys does not report a value for HbF on quality control materials, two blood samples with respectively a low and a high value for HbF were analyzed twice daily over 5 days to asses imprecision of this parameter in the Hb-pathy mode of this analyzer.
| Correlation of HbF and HbA2
Correlation 
| Sensitivity for β-thalassemia
A high HbA2 value (i.e. >3.5%) is used in the detection of β-thalassemia minor. In order to evaluate the sensitivity of the different analyzers in detecting β-thalassemia minor, HbA2 of six heterozygote β-thalassemia samples was measured to verify whether values exceeded the cut-off level for each sample.
| Sensitivity for α-thalassemia
In contrast to β-thalassemia, α-thalassemia has no specific hallmark on HPLC or CE analysis as normal levels of HbA2 do not exclude its presence. Therefore, analytical sensitivity for α-thalassemia could not be assessed. When microcytic normochromic anemia cannot be explained by iron deficiency in a patient with a normal hemoglobin separation pattern, molecular analysis for α-thalassemia detection is required.
| Sensitivity for Hb variants
The 32 samples of patients with a known Hb variant were analyzed on the different analyzers and the detection and identification of the different types of variants was studied. Because of insufficient sample volume, not all samples were measured on all modes of the different analyzers. As a consequence, the number of analyzed samples was 28
for the HbA1c mode on the HLC-723G8, 25 for the HbA1c mode on the Capillarys and 30 for the D-100 (Table 5 ).
| Statistics
Statistical analysis was performed using Microsoft Excel 2013
(Microsoft Corp., Redmond, WA, USA) and MEDCALC version 12.6
(MedCalc Software bvba, Mariakerke, Belgium). Imprecision was calculated using the coefficient of variation (CV). Correlation between methods was measured by Passing-Bablok regression to determine proportional and constant bias via, respectively, slopes and intercepts of the regression lines of pairwise assay comparisons.
| RESULTS
| Imprecision
Imprecision was <10% for both HbF and HbA2 in all modes of all analyzers ( 
| Correlation of HbF and HbA2
The correlations between values obtained with individual analyzers and the mean reference comparator value are shown in Table 3 no value for HbF was reported as the result was below the detection limit (<0.5%). For two of the six samples for which a value was reported, the result was significantly higher compared to the Hb-pathy mode of the Capillarys and as compared to the gold standard (sample 1: 6.4%, 1.9% and 2.2% respectively; sample 2: 8.1%, 2.8% and 2.6% respectively).
| Sensitivity for β-thalassemia
The clinical significance of the proportional and constant biases for HbA2 demonstrated in the correlation study was assessed by evaluating the sensitivity for detecting β-thalassemia minor, using a cutoff of 3.5% ( Moreover, co-elution of HbE with HbA2 is indicated by an error flag.
| Sensitivity for Hb variants
In the HbA1c-mode of the Capillarys, all measured variants were detected as an aberrant peak. In this mode, variants are never identified.
Likewise, all variants were detected in the Hb-pathy mode of this device but two HbS out of four homozygous samples and one HbC out of five heterozygous samples did not migrate in the appropriate identification zone. In case of the unidentified homozygous HbS samples, correct identification was obtained after 1/1 mixing with a normal whole blood sample, as recommended by the manufacturer. In case of the unidentified heterozygous HbC sample, none of the identification zones were named by the software for an unknown reason. In such situation the manufacturer recommends to repeat the analysis, which
was not done in this study.
| DISCUSSION
Automated analyzers either measure HbA1c and screen for hemoglobinopathies in a single mode, or in two different dedicated modes on the same analyzer. In the latter case, several manipulations of the analyzer need to be performed when changing between different modes, including switching of reagents and performing quality controls. Longer separation procedures entail a more distinctive pattern of Hb fractions, at the expense of longer turnaround times.
When separate modes are present, focus in the HbA1c mode lies on a short turnaround time resulting in a lower separation capacity, while the Hb-pathy mode focusses on separation capacity inducing longer turnaround times. Devices that work in a single mode do not achieve the short turnaround time of a dedicated HbA1c mode, nor the separation capacity of a dedicated Hb-pathy mode, but they try to find the ideal compromise between both, thereby avoiding the need to switch between modes.
The present study compares four hemoglobin separation devices in their ability to detect and identify hemoglobinopathies. As two of these analyzers, the HA8180T and the D100, only recently appeared on the market, their analytical performance has not been evaluated before. Both analyzers operate in a single mode. The two other analyzers, the HLC-723G8 and the Capillarys, operate in two modes. The good analytical performance of the dedicated Hb-pathy mode of these latter analyzers has been well established before, 2-6 but whether their
HbA1c mode is sensitive enough to be used as a screening tool for the presence of hemoglobinopathies remained to be investigated.
| D-100
The D-100 shows a low imprecision and a clinically acceptable correlation with other devices for HbF. Although the main objective of the D-100 is HbA1c analysis and not hemoglobinopathy analysis, thereby operating in a single mode, all tested Hb variants were detected and the most common ones (Hb C, D, E and S) were correctly identified.
The major drawback of this analyzer in its present stage is the lack of HbA2 measurement, making it unsuitable to detect β-thalassemia.
| HA 8180T
HA 8180T operates in a single mode for both HbA1c measurement and hemoglobinopathy detection, making it a versatile and userfriendly device for routine laboratory use. It measures both HbF and HbA2 and has a low imprecision and acceptable correlation for both parameters. The HA 8180T was the only evaluated device that obtained imprecision levels for HbA2 below 2% on both measured samples, as recommended by the ICSH. 7 Based on a cut-off value for HbA2 of 3.5%, five out of six β-thalassemia cases were detected. The missed case demonstrated a HbA2 value around the chosen cut-off. This borderline value for HbA2 was measured in a sample from a 78-year old female patient and can be explained by the fact that she was a known β-thalassemia patient and received red blood cell transfusions in the weeks preceding blood sampling, lowering HbA2 levels. Indeed, 
| HLC-723G8
HLC-723G8 operates in two modes, one for HbA1c and one for hemoglobinopathies. Switching between modes implies changing the analytical column and liquid reagents and performing separate quality controls. The HbA1c mode demonstrates a low imprecision and a clinically acceptable correlation for HbF. HbA2 is not quantified in this mode, so β-thalassemia cannot be detected. Two Hb variants were missed in the HbA1c mode: the rare variants Hb J-Baltimore and Hb
Muravera. In the dedicated Hb-pathy mode, all variants were correctly detected. This Hb-pathy mode of HLC-723G8 has a low imprecision and acceptable correlation for both HbF and HbA2. Users should be aware that HbE is not identified as a separate peak but co-elutes with HbA2. As for the HA 8180T, one out of six β-thalassemias was missed because of a value close to the cut-off.
| Capillarys 2 Flex Piercing
The Capillarys also operates in a HbA1c mode and a Hb-pathy mode.
Switching between modes implies changing liquid reagents and performing separate quality controls. A low imprecision was demonstrated for HbA2 in the HbA1c mode. Correlation of HbF with the gold standard was poor in this mode, although admittedly, the number of samples for which a result was reported was low. In contrast, cor- Underlined+bold: not detected; Italic+bold: incorrect identification of Hb C, D, E or S (aberrant fraction detected, but incorrectly identified).
a Correct identification after mixture with normal blood sample.
